FDA releases revised draft guidance on CDS software, final guidelines on ‘device’ definitions for software such as wellness apps

The new guidances are intended to provide clarity on which products are or are not subject to regulatory enforcement, and to bring the agency’s efforts into compliance with provisions of the 21st Century Cures Act.